Impact of hepatitis C virus status in pancreas transplantation: A case controlled study

Clinical Transplantation

Volumn 16, Issue 4, 2002, Pages 243-251

  Honaker, Marsha R ^a   Stratta, Robert J ^a   Lo, Agnes ^a   Egidi, M Francesca ^a   Shokouh Amiri, M Hosein ^a   Grewal, Hani P ^a   Alloway, Rita R ^a   Gaber, Lillian W ^a   Hardinger, Karen L ^a   Gaber, A Osama ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Graft function; Graft survival; Hepatitis C; Kidney transplantation; Morbidity; Outcomes; Pancreas transplantation

Indexed keywords

AMYLASE; AZATHIOPRINE; C PEPTIDE; COTRIMOXAZOLE; CREATININE; FLUCONAZOLE; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; PENTAMIDINE; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGE; AMYLASE BLOOD LEVEL; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENDER; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RACE; RECIPIENT; REVIEW; SEPSIS; SURGICAL TECHNIQUE; DISEASE FREE SURVIVAL; RISK;

CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HUMAN; MORBIDITY; PANCREAS TRANSPLANTATION; PROGNOSIS; RISK; HUMANS;

EID: 0036020615     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.01116.x     Document Type: Review

References (26)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
2. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
3. Membrano-proliferative glomerulonephritis associated with hepatitis C virus infection
4. Renal manifestations of hepatitis C virus infection
5. High prevalence of autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
6. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection
7. High prevalence of hepatitis C virus infection in diabetic patients
8. Impact of hepatitis B and C virus on kidney transplantation outcome
9. Retrospective study on the impact of hepatitis C virus infection of kidney transplant patients over 20 years
10. Impaired kidney transplant survival in patients with anti-bodies to hepatitis C virus
11. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
12. Lymphocyte subsets in renal allograft recipients with chronic hepatitis C virus infection
13. Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients
14. The safety of pancreasrenal transplantation in the hepatitis C positive patient
15. Results of pancreas transplantation with portal venous and enteric drainage
16. In vivo trophism of hepatitis C virus genomic sequences in hematopoictic cells: Influence of viral load, viral genotypes, and cell phenotype
17. Hepatitis C virus infection involves CD34 (+) hematopoietic progenitor cells in hepatitis C virus chronic carriers
18. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: Preliminary application to liver transplanation model
19. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues
20. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients
21. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver
22. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients
23. Hepatitis C quasispecies in patients infected with HIV-1: Correlation with extrahepatic viral replication
24. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma
25. Differences in hypervariable region I quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells
26. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis